Opportunity Alert: Stocks from India's Emerging Businesses
Here is the latest financial fact sheet of BAL PHARMA. For more details, see the BAL PHARMA quarterly results and BAL PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 2.3 |
No. of shares | m | 15.69 |
1 Week | % | 3.2 |
1 Month | % | 9.7 |
1 Year | % | -10.3 |
52 week H/L | Rs | 105.4/63.4 |
No. of Mths Year Ending |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
5-Yr Chart Click to enlarge
|
---|
BAL PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 128 | 109 | 79 | 73 | 149 | |
Low | Rs | 75 | 63 | 24 | 29 | 53 | |
Sales per share (Unadj.) | Rs | 146.2 | 158.8 | 120.7 | 169.0 | 189.8 | |
Earnings per share (Unadj.) | Rs | 0.3 | 1.5 | -9.1 | 3.2 | 3.8 | |
Diluted earnings per share | Rs | 0.2 | 1.4 | -8.2 | 3.0 | 3.6 | |
Cash flow per share (Unadj.) | Rs | 5.0 | 5.9 | -3.7 | 9.6 | 9.9 | |
Dividends per share (Unadj.) | Rs | 1.00 | 1.00 | 0 | 1.00 | 1.00 | |
Adj. dividends per share | Rs | 0.90 | 0.90 | 0.00 | 0.94 | 0.94 | |
Avg Dividend yield | % | 1.0 | 1.2 | 0 | 2.0 | 1.0 | |
Book value per share (Unadj.) | Rs | 45.9 | 47.0 | 37.0 | 35.5 | 38.9 | |
Adj. book value per share | Rs | 41.4 | 42.5 | 33.4 | 33.6 | 36.8 | |
Shares outstanding (eoy) | m | 14.17 | 14.17 | 14.17 | 14.82 | 14.82 | |
Price / Sales ratio | x | 0.7 | 0.5 | 0.4 | 0.3 | 0.5 | |
Avg P/E ratio | x | 382.5 | 56.5 | -5.6 | 16.0 | 26.2 | |
P/CF ratio (eoy) | x | 20.2 | 14.6 | -13.9 | 5.3 | 10.1 | |
Price / Book Value ratio | x | 2.2 | 1.8 | 1.4 | 1.4 | 2.6 | |
Dividend payout | % | 376.9 | 65.8 | 0 | 31.5 | 26.0 | |
Avg Mkt Cap | Rs m | 1,440 | 1,217 | 727 | 753 | 1,494 | |
Total wages/salary | Rs m | 522 | 503 | 504 | 419 | 473 |
BAL PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 2,071 | 2,250 | 1,711 | 2,505 | 2,812 | |
Other income | Rs m | 17 | 10 | 19 | 11 | 52 | |
Total revenues | Rs m | 2,088 | 2,260 | 1,729 | 2,517 | 2,864 | |
Gross profit | Rs m | 173 | 177 | 50 | 246 | 240 | |
Depreciation | Rs m | 68 | 62 | 77 | 95 | 90 | |
Interest | Rs m | 94 | 127 | 127 | 122 | 109 | |
Profit before tax | Rs m | 29 | -2 | -135 | 41 | 92 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 25 | -24 | -6 | -6 | 35 | |
Profit after tax | Rs m | 4 | 22 | -129 | 47 | 57 | |
Gross profit margin | % | 8.4 | 7.9 | 2.9 | 9.8 | 8.5 | |
Effective tax rate | % | 86.9 | 1,166.0 | 4.7 | -14.9 | 37.9 | |
Net profit margin | % | 0.2 | 1.0 | -7.5 | 1.9 | 2.0 |
BAL PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,848 | 1,830 | 1,574 | 1,641 | 1,846 | |
Current liabilities | Rs m | 1,544 | 1,632 | 1,595 | 1,525 | 1,656 | |
Net working cap to sales | % | 14.7 | 8.8 | -1.2 | 4.6 | 6.7 | |
Current ratio | x | 1.2 | 1.1 | 1.0 | 1.1 | 1.1 | |
Inventory Days | Days | 7 | 7 | 15 | 11 | 9 | |
Debtors Days | Days | 1,129 | 1,049 | 1,058 | 979 | 978 | |
Net fixed assets | Rs m | 754 | 783 | 810 | 759 | 760 | |
Share capital | Rs m | 142 | 142 | 142 | 148 | 148 | |
"Free" reserves | Rs m | 508 | 525 | 383 | 378 | 429 | |
Net worth | Rs m | 650 | 666 | 524 | 526 | 577 | |
Long term debt | Rs m | 347 | 288 | 231 | 239 | 270 | |
Total assets | Rs m | 2,602 | 2,613 | 2,384 | 2,401 | 2,605 | |
Interest coverage | x | 1.3 | 1.0 | -0.1 | 1.3 | 1.8 | |
Debt to equity ratio | x | 0.5 | 0.4 | 0.4 | 0.5 | 0.5 | |
Sales to assets ratio | x | 0.8 | 0.9 | 0.7 | 1.0 | 1.1 | |
Return on assets | % | 3.8 | 5.7 | -0.1 | 7.0 | 6.4 | |
Return on equity | % | 0.6 | 3.2 | -24.6 | 9.0 | 9.9 | |
Return on capital | % | 12.3 | 13.1 | -1.1 | 21.2 | 23.7 | |
Exports to sales | % | 47.7 | 56.2 | 60.5 | 60.0 | 65.3 | |
Imports to sales | % | 19.9 | 16.1 | 15.6 | 22.7 | 27.7 | |
Exports (fob) | Rs m | 987 | 1,266 | 1,035 | 1,504 | 1,836 | |
Imports (cif) | Rs m | 412 | 362 | 266 | 568 | 779 | |
Fx inflow | Rs m | 987 | 1,266 | 1,035 | 1,504 | 1,836 | |
Fx outflow | Rs m | 432 | 390 | 292 | 586 | 796 | |
Net fx | Rs m | 556 | 875 | 742 | 918 | 1,040 |
BAL PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 6 | 78 | 232 | 223 | 277 | |
From Investments | Rs m | -36 | -80 | -47 | -55 | -95 | |
From Financial Activity | Rs m | 35 | 0 | -200 | -166 | -181 | |
Net Cashflow | Rs m | 5 | -3 | -16 | 2 | 1 |
Share Holding
Shareholding as on Mar 2023
|
Company Information
|
CHM: Shailesh Siroya | COMP SEC: Preeti Singh | YEAR OF INC: 1987 | BSE CODE: 524824 | FV (Rs): 10 | DIV YIELD (%): 1.1 |
More Pharmaceuticals Company Fact Sheets: AUROBINDO PHARMA CIPLA ZYDUS LIFESCIENCES PIRAMAL ENTERPRISES LUPIN
Compare BAL PHARMA With: AUROBINDO PHARMA CIPLA ZYDUS LIFESCIENCES PIRAMAL ENTERPRISES LUPIN
After opening the day flat, Indian share markets remained subdued throughout the session and ended lower.